Literature DB >> 22903011

Consanguinity and inflammatory bowel diseases: is there a relation?

Mohammad El Mouzan1, Mohammad Al-Mofarreh, Asaad Assiri, Yassin Hamid, Anjum Saeed.   

Abstract

OBJECTIVE: The aim of the present study was to investigate the relation between consanguinity and inflammatory bowel diseases (IBD).
METHODS: Review of the medical records of children with a final diagnosis of IBD to determine age, sex, and type of IBD, supplemented by information on consanguinity and family history (FH) of IBD in relatives. There were 138 children, ages 1.4 to 19.3 years, and 50% were girls.
RESULTS: The prevalence of consanguinity was 50%, 53%, 39% and 60% in IBD, Crohn disease (CD), ulcerative colitis (UC), and controls, respectively. There was a significantly higher prevalence of consanguinity in controls than in patients with IBD and UC (P = 0.02 and 0.026, respectively), whereas the difference between CD patients and controls was not significant (P = 0.20). The prevalence of first cousin consanguinity was 71%, 73.2%, 61.5% and 70.5% in patients with IBD, CD, UC, and controls, respectively, indicating no significant difference between these conditions and controls (P = 0.95, P = 0.78, P = 0.33, respectively). There was no significant difference in the prevalence of consanguinity in the parents of children with or without a FH of either CD (P = 0.89) or UC (P = 0.32).
CONCLUSIONS: There is no significant relation between parental consanguinity and IBD in this population, especially when there is no FH of disease, suggesting reduced genetic susceptibility; however, further studies including larger sample size and details of FH of consanguinity and IBD in multiple generations are needed for further definitions of the role of consanguinity.

Entities:  

Mesh:

Year:  2013        PMID: 22903011     DOI: 10.1097/MPG.0b013e31826d9987

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  7 in total

1.  Is consanguinity prevalence decreasing in Saudis?: A study in two generations.

Authors:  Arjumand Sultan Warsy; May Hamad Al-Jaser; Abeer Albdass; Sooad Al-Daihan; Mohammad Alanazi
Journal:  Afr Health Sci       Date:  2014-06       Impact factor: 0.927

Review 2.  Incidence, Prevalence, and Clinical Epidemiology of Inflammatory Bowel Disease in the Arab World: A Systematic Review and Meta-Analysis.

Authors:  Mahmoud Mosli; Sameer Alawadhi; Fuad Hasan; Antoine Abou Rached; Faisal Sanai; Silvio Danese
Journal:  Inflamm Intest Dis       Date:  2021-09-07

3.  Inflammatory bowel disease in Turkish children.

Authors:  Murat Cakir; Fatih Unal; Gonul Dinler; Masallah Baran; Hasan Ali Yuksekkaya; Gokhan Tumgor; Erhun Kasirga; Ayhan Gazi Kalayci; Sema Aydogdu
Journal:  World J Pediatr       Date:  2015-10-11       Impact factor: 2.764

4.  Clinical Pattern of Early-Onset Inflammatory Bowel Disease in Saudi Arabia: A Multicenter National Study.

Authors:  Abdulrahman Al-Hussaini; Mohammad El Mouzan; Mohammed Hasosah; Ali Al-Mehaidib; Khalid ALSaleem; Omar I Saadah; Mohammed Al-Edreesi
Journal:  Inflamm Bowel Dis       Date:  2016-08       Impact factor: 5.325

5.  A cross-sectional survey of multi-generation inflammatory bowel disease consanguinity and its relationship with disease onset.

Authors:  Mahmoud Mosli; Abdulelah Alzahrani; Showlag Showlag; Abdullah Alshehri; Ahmed Hejazi; Majed Alnefaie; Adel Almaymuni; Mubarak Abdullahi; Mohammed Albeshir; Eman Alsulais; Hani Jawa; Emad Aljahdli; Salem Bazarah; Yousif Qari
Journal:  Saudi J Gastroenterol       Date:  2017 Nov-Dec       Impact factor: 2.485

6.  Genetic analysis of four consanguineous multiplex families with inflammatory bowel disease.

Authors:  Noam Ben-Yosef; Matthew Frampton; Elena R Schiff; Saleh Daher; Fadi Abu Baker; Rifaat Safadi; Eran Israeli; Anthony W Segal; Adam P Levine
Journal:  Gastroenterol Rep (Oxf)       Date:  2021-07-13

7.  Regional variation of pediatric inflammatory bowel disease in Saudi Arabia: Results from a multicenter study.

Authors:  Mohammad I El Mouzan; Mohammed H AlEdreesi; Mohammed Y Hasosah; Abdulrahman A Al-Hussaini; Ahmad A Al Sarkhy; Asaad A Assiri
Journal:  World J Gastroenterol       Date:  2020-01-28       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.